| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |